Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
MHC Class II Auto-Antigen Presentation is Unconventional.

Frontiers in immunology

Sadegh-Nasseri S, Kim A.
PMID: 26257739
Front Immunol. 2015 Jul 22;6:372. doi: 10.3389/fimmu.2015.00372. eCollection 2015.

Antigen presentation is highly critical in adoptive immunity. Only by interacting with antigens presented by major histocompatibility complex class II molecules, helper T cells can be stimulated to fight infections or diseases. The degradation of a full protein into...

Cite
Sadegh-Nasseri S, Kim A. MHC Class II Auto-Antigen Presentation is Unconventional. Front Immunol. 2015;6:372doi: 10.3389/fimmu.2015.00372.
Sadegh-Nasseri, S., & Kim, A. (2015). MHC Class II Auto-Antigen Presentation is Unconventional. Frontiers in immunology, 6372. https://doi.org/10.3389/fimmu.2015.00372
Sadegh-Nasseri, Scheherazade, and Kim, AeRyon. "MHC Class II Auto-Antigen Presentation is Unconventional." Frontiers in immunology vol. 6 (2015): 372. doi: https://doi.org/10.3389/fimmu.2015.00372
Sadegh-Nasseri S, Kim A. MHC Class II Auto-Antigen Presentation is Unconventional. Front Immunol. 2015 Jul 22;6:372. doi: 10.3389/fimmu.2015.00372. eCollection 2015. PMID: 26257739; PMCID: PMC4510428.
Copy Download .nbib Format: NLM
Analysis of Signals Leading to Differentiation of Immature HL-60 after Administration of IL-4.

Mediators of inflammation

Vassiliadis S.
PMID: 18475589
Mediators Inflamm. 1994;3(6):415-8. doi: 10.1155/S096293519400058X.

Treatment of acute myeloid leukaemia (AML) cells with differentiation agents leads not only to the acquisition of normal phenotypes but also contributes to the understanding of special immuno-haematology issues. For instance, induction of HLA-DR antigens on human promyelocytic leukaemia...

Cite
Vassiliadis S. Analysis of Signals Leading to Differentiation of Immature HL-60 after Administration of IL-4. Mediators Inflamm. 1994;3(6):415-8doi: 10.1155/S096293519400058X.
Vassiliadis, S. (1994). Analysis of Signals Leading to Differentiation of Immature HL-60 after Administration of IL-4. Mediators of inflammation, 3(6), 415-8. https://doi.org/10.1155/S096293519400058X
Vassiliadis, S. "Analysis of Signals Leading to Differentiation of Immature HL-60 after Administration of IL-4." Mediators of inflammation vol. 3,6 (1994): 415-8. doi: https://doi.org/10.1155/S096293519400058X
Vassiliadis S. Analysis of Signals Leading to Differentiation of Immature HL-60 after Administration of IL-4. Mediators Inflamm. 1994;3(6):415-8. doi: 10.1155/S096293519400058X. PMID: 18475589; PMCID: PMC2365590.
Copy Download .nbib Format: NLM
Autoimmune liver disease.

Current opinion in gastroenterology

Czaja AJ.
PMID: 17031168
Curr Opin Gastroenterol. 2001 May;17(3):268-75. doi: 10.1097/00001574-200105000-00010.

Autoimmune hepatitis in children may be associated with sclerosing cholangitis in the absence of inflammatory bowel disease. Wilson disease can have clinical and laboratory features that resemble autoimmune hepatitis, and it may respond initially to corticosteroids. Soluble HLA-DR antigens...

Cite
Czaja AJ. Autoimmune liver disease. Curr Opin Gastroenterol. 2001;17(3):268-75doi: 10.1097/00001574-200105000-00010.
Czaja, A. J. (2001). Autoimmune liver disease. Current opinion in gastroenterology, 17(3), 268-75. https://doi.org/10.1097/00001574-200105000-00010
Czaja, A J. "Autoimmune liver disease." Current opinion in gastroenterology vol. 17,3 (2001): 268-75. doi: https://doi.org/10.1097/00001574-200105000-00010
Czaja AJ. Autoimmune liver disease. Curr Opin Gastroenterol. 2001 May;17(3):268-75. doi: 10.1097/00001574-200105000-00010. PMID: 17031168.
Copy Download .nbib Format: NLM
Origin of lymph node-derived lymphocytes in human hepatic allografts.

Clinical transplants

Fung JJ, Zeevi A, Demetris AJ, Starzl TE, Markus B, Chen K, Marrarri M, Duquesnoy RJ.
PMID: 23258949
Clin Transpl. 1989;3:316-324.

Hepatic allograft-derived lymph nodes were examined in the post-transplant period on order to determine the origin of lymphocytes and structural elements of the lymph node. Histologic assessment and immunohistochemical studies verified that T-cell infiltration of donor lymph nodes by...

Cite
Fung JJ, Zeevi A, Demetris AJ, et al. Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl. 1989;3:316-324
Fung, J. J., Zeevi, A., Demetris, A. J., Starzl, T. E., Markus, B., Chen, K., Marrarri, M., & Duquesnoy, R. J. (1989). Origin of lymph node-derived lymphocytes in human hepatic allografts. Clinical transplants, 3316-324.
Fung, John J, et al. "Origin of lymph node-derived lymphocytes in human hepatic allografts." Clinical transplants vol. 3 (1989): 316-324.
Fung JJ, Zeevi A, Demetris AJ, Starzl TE, Markus B, Chen K, Marrarri M, Duquesnoy RJ. Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl. 1989;3:316-324. PMID: 23258949; PMCID: PMC3524991.
Copy Download .nbib Format: NLM
Human leukocyte antigen variation among Iranian renal transplant recipients.

Journal of nephropathology

Einollahi B, Rostami Z, Teimoori M.
PMID: 24475410
J Nephropathol. 2012 Oct;1(3):164-9. doi: 10.5812/nephropathol.8114. Epub 2012 Oct 01.

BACKGROUND: HLA typing analysis is important in renal transplant patients.OBJECTIVES: We made a plan to determine the most frequent HLA antigens in Iranian kidney transplant patients.PATIENTS AND METHODS: In a retrospective cross sectional study, HLA patterns were defined in...

Cite
Einollahi B, Rostami Z, Teimoori M. Human leukocyte antigen variation among Iranian renal transplant recipients. J Nephropathol. 2012;1(3):164-9doi: 10.5812/nephropathol.8114.
Einollahi, B., Rostami, Z., & Teimoori, M. (2012). Human leukocyte antigen variation among Iranian renal transplant recipients. Journal of nephropathology, 1(3), 164-9. https://doi.org/10.5812/nephropathol.8114
Einollahi, Behzad, et al. "Human leukocyte antigen variation among Iranian renal transplant recipients." Journal of nephropathology vol. 1,3 (2012): 164-9. doi: https://doi.org/10.5812/nephropathol.8114
Einollahi B, Rostami Z, Teimoori M. Human leukocyte antigen variation among Iranian renal transplant recipients. J Nephropathol. 2012 Oct;1(3):164-9. doi: 10.5812/nephropathol.8114. Epub 2012 Oct 01. PMID: 24475410; PMCID: PMC3886157.
Copy Download .nbib Format: NLM
Further intricacy of HLA-DR antigens.

Immunology today

Guy K, Van Heyningen V.
PMID: 25290052
Immunol Today. 1982 Sep;3(9):236-7. doi: 10.1016/0167-5699(82)90008-1.

No abstract available.

Cite
Guy K, Van Heyningen V. Further intricacy of HLA-DR antigens. Immunol Today. 1982;3(9):236-7doi: 10.1016/0167-5699(82)90008-1.
Guy, K., & Van Heyningen, V. (1982). Further intricacy of HLA-DR antigens. Immunology today, 3(9), 236-7. https://doi.org/10.1016/0167-5699(82)90008-1
Guy, K, and Van Heyningen, V. "Further intricacy of HLA-DR antigens." Immunology today vol. 3,9 (1982): 236-7. doi: https://doi.org/10.1016/0167-5699(82)90008-1
Guy K, Van Heyningen V. Further intricacy of HLA-DR antigens. Immunol Today. 1982 Sep;3(9):236-7. doi: 10.1016/0167-5699(82)90008-1. PMID: 25290052.
Copy Download .nbib Format: NLM
The Predictive Value of HLA-DR Matching and Cytokine Gene Polymorphisms in Renal Allograft Acute Rejection: a Living-unrelated Donor (LURD) Study.

Iranian journal of immunology : IJI

Tajik N, Kazemi T, Delbandi A, Ghods A, Salek Moghaddam A.
PMID: 18685174
Iran J Immunol. 2006 Dec;3(4):150-6. doi: IJIv3i4A1.

BACKGROUND: In addition to Human Leukocyte Antigens (HLA) compatibility, gene polymorphism in cytokines might be important in the quality of allogeneic immune response.OBJECTIVES: In this study HLA-DR matching and a number of cytokine gene polymorphisms have been evaluated in...

Cite
Tajik N, Kazemi T, Delbandi A, et al. The Predictive Value of HLA-DR Matching and Cytokine Gene Polymorphisms in Renal Allograft Acute Rejection: a Living-unrelated Donor (LURD) Study. Iran J Immunol. 2006;3(4):150-6doi: IJIv3i4A1.
Tajik, N., Kazemi, T., Delbandi, A., Ghods, A., & Salek Moghaddam, A. (2006). The Predictive Value of HLA-DR Matching and Cytokine Gene Polymorphisms in Renal Allograft Acute Rejection: a Living-unrelated Donor (LURD) Study. Iranian journal of immunology : IJI, 3(4), 150-6. https://doi.org/IJIv3i4A1
Tajik, Nader, et al. "The Predictive Value of HLA-DR Matching and Cytokine Gene Polymorphisms in Renal Allograft Acute Rejection: a Living-unrelated Donor (LURD) Study." Iranian journal of immunology : IJI vol. 3,4 (2006): 150-6. doi: https://doi.org/IJIv3i4A1
Tajik N, Kazemi T, Delbandi A, Ghods A, Salek Moghaddam A. The Predictive Value of HLA-DR Matching and Cytokine Gene Polymorphisms in Renal Allograft Acute Rejection: a Living-unrelated Donor (LURD) Study. Iran J Immunol. 2006 Dec;3(4):150-6. doi: IJIv3i4A1. PMID: 18685174.
Copy Download .nbib Format: NLM
T cell subpopulations and cytokine levels in hemodialysis patients.

Human immunology

Lisowska KA, Storoniak H, Dębska-Ślizień A.
PMID: 34802797
Hum Immunol. 2021 Nov 18; doi: 10.1016/j.humimm.2021.11.003. Epub 2021 Nov 18.

HD patients have impaired adaptive immune responses, which might depend on the primary cause of chronic kidney disease (CKD). We analyzed percentages of T cells subpopulations with the expression of CD69, CD25, CD95, and HLA-DR antigens in HD patients...

Cite
Lisowska KA, Storoniak H, Dębska-Ślizień A. T cell subpopulations and cytokine levels in hemodialysis patients. Hum Immunol. 2021;doi: 10.1016/j.humimm.2021.11.003.
Lisowska, K. A., Storoniak, H., & Dębska-Ślizień, A. (2021). T cell subpopulations and cytokine levels in hemodialysis patients. Human immunology, . https://doi.org/10.1016/j.humimm.2021.11.003
Lisowska, Katarzyna A, et al. "T cell subpopulations and cytokine levels in hemodialysis patients." Human immunology vol. (2021). doi: https://doi.org/10.1016/j.humimm.2021.11.003
Lisowska KA, Storoniak H, Dębska-Ślizień A. T cell subpopulations and cytokine levels in hemodialysis patients. Hum Immunol. 2021 Nov 18; doi: 10.1016/j.humimm.2021.11.003. Epub 2021 Nov 18. PMID: 34802797.
Copy Download .nbib Format: NLM
HLA-DO and Its Role in MHC Class II Antigen Presentation.

Frontiers in immunology

Poluektov YO, Kim A, Sadegh-Nasseri S.
PMID: 24009612
Front Immunol. 2013 Aug 29;4:260. doi: 10.3389/fimmu.2013.00260. eCollection 2013.

Helper T cells are stimulated to fight infections or diseases upon recognition of peptides from antigens that are processed and presented by the proteins of Major Histocompatibility Complex (MHC) Class II molecules. Degradation of a full protein into small...

Cite
Poluektov YO, Kim A, Sadegh-Nasseri S. HLA-DO and Its Role in MHC Class II Antigen Presentation. Front Immunol. 2013;4:260doi: 10.3389/fimmu.2013.00260.
Poluektov, Y. O., Kim, A., & Sadegh-Nasseri, S. (2013). HLA-DO and Its Role in MHC Class II Antigen Presentation. Frontiers in immunology, 4260. https://doi.org/10.3389/fimmu.2013.00260
Poluektov, Yuri O, et al. "HLA-DO and Its Role in MHC Class II Antigen Presentation." Frontiers in immunology vol. 4 (2013): 260. doi: https://doi.org/10.3389/fimmu.2013.00260
Poluektov YO, Kim A, Sadegh-Nasseri S. HLA-DO and Its Role in MHC Class II Antigen Presentation. Front Immunol. 2013 Aug 29;4:260. doi: 10.3389/fimmu.2013.00260. eCollection 2013. PMID: 24009612; PMCID: PMC3756479.
Copy Download .nbib Format: NLM
Vaccination against rheumatoid arthritis: concepts and progress.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Moreland LW, Koopman WJ.
PMID: 18020497
BioDrugs. 1997 Aug;8(2):87-95. doi: 10.2165/00063030-199708020-00002.

Recently, interest has grown in the potential benefit of vaccination approaches in humans with rheumatoid arthritis. Approaches evaluated include the use of T cell receptor peptide vaccines, autologous T cells, major histocompatibility complex (MHC) peptides, allogeneic mononuclear cells and...

Cite
Moreland LW, Koopman WJ. Vaccination against rheumatoid arthritis: concepts and progress. BioDrugs. 1997;8(2):87-95doi: 10.2165/00063030-199708020-00002.
Moreland, L. W., & Koopman, W. J. (1997). Vaccination against rheumatoid arthritis: concepts and progress. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 8(2), 87-95. https://doi.org/10.2165/00063030-199708020-00002
Moreland, L W, and Koopman, W J. "Vaccination against rheumatoid arthritis: concepts and progress." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 8,2 (1997): 87-95. doi: https://doi.org/10.2165/00063030-199708020-00002
Moreland LW, Koopman WJ. Vaccination against rheumatoid arthritis: concepts and progress. BioDrugs. 1997 Aug;8(2):87-95. doi: 10.2165/00063030-199708020-00002. PMID: 18020497.
Copy Download .nbib Format: NLM
Association of Hypertrophic Obstructive Cardiomyopathy with Rheumatoid Arthritis.

Cureus

Dawood M, Lateef N, Tauseef A, Patel J.
PMID: 29531881
Cureus. 2018 Jan 05;10(1):e2028. doi: 10.7759/cureus.2028.

Our article refers to a 50-year-old woman with previously diagnosed rheumatoid arthritis (RA) who presented with symptoms of dyspnea on exertion and dizziness. An echocardiogram revealed a 17-mm asymmetric interventricular septum hypertrophy and systolic anterior motion of the anterior...

Cite
Dawood M, Lateef N, Tauseef A, et al. Association of Hypertrophic Obstructive Cardiomyopathy with Rheumatoid Arthritis. Cureus. 2018;10(1):e2028doi: 10.7759/cureus.2028.
Dawood, M., Lateef, N., Tauseef, A., & Patel, J. (2018). Association of Hypertrophic Obstructive Cardiomyopathy with Rheumatoid Arthritis. Cureus, 10(1), e2028. https://doi.org/10.7759/cureus.2028
Dawood, Mustafa, et al. "Association of Hypertrophic Obstructive Cardiomyopathy with Rheumatoid Arthritis." Cureus vol. 10,1 (2018): e2028. doi: https://doi.org/10.7759/cureus.2028
Dawood M, Lateef N, Tauseef A, Patel J. Association of Hypertrophic Obstructive Cardiomyopathy with Rheumatoid Arthritis. Cureus. 2018 Jan 05;10(1):e2028. doi: 10.7759/cureus.2028. PMID: 29531881; PMCID: PMC5837261.
Copy Download .nbib Format: NLM
Monoclonal antibodies to HLA-DR antigens.

Immunology today

Beckman I.
PMID: 25291364
Immunol Today. 1984 Feb;5(2):29-32. doi: 10.1016/0167-5699(84)90019-7.

Monoclonal antibodies (Mabs) have been invaluable in the study of human MHC class-11 (or la-like) antigens. For this to continue some pooling of resources was needed and in 1982 the British Medical Research Council's Clinical and Population Cytogenetics Unit...

Cite
Beckman I. Monoclonal antibodies to HLA-DR antigens. Immunol Today. 1984;5(2):29-32doi: 10.1016/0167-5699(84)90019-7.
Beckman, I. (1984). Monoclonal antibodies to HLA-DR antigens. Immunology today, 5(2), 29-32. https://doi.org/10.1016/0167-5699(84)90019-7
Beckman, I. "Monoclonal antibodies to HLA-DR antigens." Immunology today vol. 5,2 (1984): 29-32. doi: https://doi.org/10.1016/0167-5699(84)90019-7
Beckman I. Monoclonal antibodies to HLA-DR antigens. Immunol Today. 1984 Feb;5(2):29-32. doi: 10.1016/0167-5699(84)90019-7. PMID: 25291364.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries